Serencio, Cesar J.
HRN: 13-20-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2024
CEFTAZIDIME 1GM (VIAL)
01/08/2024
01/15/2024
IV
1g
Q8
CAP MR T/C PTB Relapse
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes